Kampmann, C; Linhart, A; Devereux, RB et al.
Effect of Agalsidase Alfa Replacement Therapy on Fabry Disease-Related Hypertrophic Cardiomyopathy: A 12-to 36-Month, Retrospective, Blinded Echocardiographic Pooled AnalysisCLINICAL THERAPEUTICS. Bd. 31. H. 9. 2009 S. 1966-1976
Thomaidis, T; Relle, M; Reinke, J et al.
Effect of enzyme replacement therapy (ERT) on renal function of patients with Fabry's diseaseMEDIZINISCHE KLINIK. Bd. 104. H. 9. 2009 S. 699-703
Kamin, W; Maydannik, V; Malek, FA et al.
Efficacy and tolerability of EPs 7630 in children and adolescents with acute bronchitis - A randomized, double-blind, placebo-controlled multicenter trial with a herbal drug preparation from Pelargonium sidoides rootsInt J Clin Pharmacol Ther. Bd. 48. H. 3. 2009 S. 184-91
Fuchs, O; Pfarr, N; Pohlenz, J et al.
Elevated serum triiodothyronine and intellectual and motor disability with paroxysmal dyskinesia caused by a monocarboxylate transporter 8 gene mutationDev Med Child Neurol. Bd. 51. H. 3. 2009 S. 240-4
Mehta, A; Beck, M; Elliott, P et al.
Enzyme replacement therapy with agalsidase alfa in patients with Fabry's disease: an analysis of registry dataLancet. Bd. 374. 2009 S. 1986-96
Kalkum, G; Macchiella, D; Reinke, J et al.
Enzyme replacement therapy with agalsidase alfa in pregnant women with Fabry disease.Eur J Obstet Gynecol Reprod Biol. Bd. 144. H. 1. 2009 S. 92-3
Lampe, C; Miebach, E; Kraemer, E et al.
ENZYME-REPLACEMENT THERAPY (ERT) IN MPS PATIENTS WITH CNS MANIFESTATIONMOLECULAR GENETICS AND METABOLISM. Bd. 98. H. 1-2. 2009 S. 64-64
Langer, D; Ingenbrandt, C; Wildhardt, G et al.
Epigenetic influences on the origin of intrauterine growth defectsMedizinische Genetik. Bd. 21. H. 1. 2009 S. 147
Knuf, M; Sutter, U
Erhöhtes Risiko für den plötzlichen Kindstod nach 6fach-Impfung?Internist Prax. Bd. 49. H. 4. 2009 S. 907-10
Aksakal, D; Schier, F; Huckstadt, T et al.
ESTABLISHING AN ANIMAL MODEL (PIGLETS) FOR EXAMINATION OF INTRA CARDIAC SHUNTING IN INFANCYACTA PAEDIATRICA. Bd. 98. 2009 S. 29-29